Posts

Showing posts with the label job cuts

Amazon (AMZN) to fire 30,000 Employees Starting October 28

Amazon (AMZN) says it plans to start firing as many as 30,000 employees starting tomorrow, sources told Reuters on Monday. The company is seeking to pare expenses and compensate for overhiring during the peak demand of the COVID-19 pandemic. It would be the largest job cut at the e-commerce company since 27,000 jobs were cut in late 2022. JUST IN: Amazon $AMZN to fire 30,000 employees starting tomorrow. — Watcher.Guru (@WatcherGuru) October 27, 2025 While the figure represents a small percentage of Amazon’s 1.55 million total employees, it is nearly 10% of the company’s roughly 350,000 corporate employees. Amazon has yet to comment nor confirm the Reuters report. Shares in AMZN got a slight uptick by 1.2% on Monday following the announcement, but dipped after markets closed. The latest job cuts are a continuation of the layoffs Amazon has executed over the last two years. Per Reuters, this week’s cuts are expected to impact a variety of divisions within Amazon, including hum...

Novo Nordisk To Lay Off 9,000 Jobs as Part of Restructuring

Image
Novo Nordisk will lay off 9,000 jobs as part of a restructuring plan to reignite growth amid intense competition from the drug industry. The structuring plan is expected to save the medical company close to $1.25 billion annually. The decision to fire staff comes after the firm experienced a drop in sales due to compounded copycat drugs making their way into the markets. The copycat drugs are available at cheaper rates, which has led to a major drop in revenue. Also Read: ANZ Bank To Cut 3,500 Jobs in a Major Restructure Plan Novo Nordisk To Fire 9,000 Employees by 2026 Source: LinkedIn Its rival pharmaceutical company Eli Lilly has launched compounded copycat drugs, eating into Novo Nordisk’s revenues. In addition, Novo Nordisk is facing slowing momentum in its obesity and diabetes franchises. The firm’s first highly effective obesity drug, Wegovy, was a success in both the US and European markets. After the Coronavirus lockdowns, the medical firm ramped up its hiring spree...